Aldeyra Therapeutics, Inc. (ALDX)
4.405
+0.16
(+3.89%)
USD |
NASDAQ |
Jan 15, 16:00
4.405
0.00 (0.00%)
After-Hours: 16:41
Aldeyra Therapeutics SG&A Expense (TTM): 9.186M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Vanda Pharmaceuticals, Inc. | 214.26M |
| ADMA Biologics, Inc. | 96.37M |
| Exelixis, Inc. | 530.03M |
| ACADIA Pharmaceuticals, Inc. | 523.36M |
| Anavex Life Sciences Corp. | 13.82M |